These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35841861)

  • 1. Corrigendum to "CpG-ODN formulated with a nanostructure as adjuvant for anticrotalic serum production. Studies in mice" [Toxicon 215 (2022) 28-36].
    Fusco LS; Pascual MM; Hernandez D; Sánchez Vallecillo MF; Arrieta MB; Moron G; Palma S; Maletto BA; Leiva LC
    Toxicon; 2022 Sep; 216():114. PubMed ID: 35841861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4
    Chiodetti AL; Sánchez Vallecillo MF; Dolina JS; Crespo MI; Marin C; Schoenberger SP; Allemandi DA; Palma SD; Pistoresi-Palencia MC; Morón G; Maletto BA
    Front Immunol; 2018; 9():2319. PubMed ID: 30364187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant activity of CpG-ODN formulated as a liquid crystal.
    Sánchez Vallecillo MF; Ullio Gamboa GV; Palma SD; Harman MF; Chiodetti AL; Morón G; Allemandi DA; Pistoresi-Palencia MC; Maletto BA
    Biomaterials; 2014 Mar; 35(8):2529-42. PubMed ID: 24382332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice.
    Moran MC; Bence AR; Vallecillo MFS; Lützelschwab CM; Rodriguez MG; Pardo R; Goldbaum FA; Zylberman V; Palma SD; Maletto BA; Estein SM
    Res Vet Sci; 2021 Mar; 135():217-227. PubMed ID: 33631456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG-ODN formulated with a nanostructure as adjuvant for anticrotalic serum production. Studies in mice.
    Fusco LS; Pascual MM; Hernandez D; Vallecillo MFS; Arrieta MB; Moron G; Palma S; Maletto BA; Leiva LC
    Toxicon; 2022 Aug; 215():28-36. PubMed ID: 35688266
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization of horses with Crotalus durissus terrificus (South American rattlesnake) venom. A comparison of four different procedures.
    Freitas TV; Fortes-Dias CL; Diniz CR; Velarde DT; Freitas CF
    Braz J Med Biol Res; 1991; 24(3):281-90. PubMed ID: 1823242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A liquid crystal of ascorbyl palmitate, used as vaccine platform, provides sustained release of antigen and has intrinsic pro-inflammatory and adjuvant activities which are dependent on MyD88 adaptor protein.
    Sánchez Vallecillo MF; Minguito de la Escalera MM; Aguirre MV; Ullio Gamboa GV; Palma SD; González-Cintado L; Chiodetti AL; Soldano G; Morón G; Allemandi DA; Ardavín C; Pistoresi-Palencia MC; Maletto BA
    J Control Release; 2015 Sep; 214():12-22. PubMed ID: 26188153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbyl palmitate (ASC16) as a potential inhibitor of toxicity induced by Crotalus durissus terrificus venom.
    Maslovski F; Angelina E; Alonso M; Leiva L; Fusco L
    Comp Biochem Physiol C Toxicol Pharmacol; 2024 Oct; 284():109973. PubMed ID: 39002622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved biodistribution and enhanced immune response of subunit vaccine using a nanostructure formed by self-assembly of ascorbyl palmitate.
    Marin C; Ruiz Moreno FN; Sánchez Vallecillo MF; Pascual MM; Dho ND; Allemandi DA; Palma SD; Pistoresi-Palencia MC; Crespo MI; Gomez CG; Morón G; Maletto BA
    Nanomedicine; 2024 Jun; 58():102749. PubMed ID: 38719107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Vaccine Based on Kunitz-Type Molecule Confers Protection Against
    Silvane L; Celias DP; Romagnoli PA; Maletto BA; Sanchez Vallecillo MF; Chiapello LS; Palma SD; Allemandi DA; Sanabria REF; Pruzzo CI; Motrán CC; Cervi L
    Front Immunol; 2020; 11():2087. PubMed ID: 33193292
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
    Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
    Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life.
    Pasternak JA; Ng SH; Buchanan RM; Mertins S; Mutwiri GK; Gerdts V; Wilson HL
    BMC Vet Res; 2015 Mar; 11():50. PubMed ID: 25889479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.
    Weiner GJ; Liu HM; Wooldridge JE; Dahle CE; Krieg AM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10833-7. PubMed ID: 9380720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
    Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
    Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
    McCluskie MJ; Weeratna RD; Davis HL
    Mol Med; 2000 Oct; 6(10):867-77. PubMed ID: 11126201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of rats against Fasciola hepatica using crude antigens conjugated with Freund's adjuvant or oligodeoxynucleotides.
    Cervi L; Borgonovo J; Egea M; Chiapello L; Masih D
    Vet Immunol Immunopathol; 2004 Jan; 97(1-2):97-104. PubMed ID: 14700541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG motif-based adjuvant as a replacement for Freund's complete adjuvant in a recombinant LHRH vaccine.
    Conforti VA; de Avila DM; Cummings NS; Zanella R; Wells KJ; Ulker H; Reeves JJ
    Vaccine; 2008 Feb; 26(7):907-13. PubMed ID: 18201806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing Freund's and AddaVax Adjuvant Regimens Using CpG Oligodeoxynucleotides.
    Hawksworth D
    Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):195-199. PubMed ID: 30281392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Montanides.
    Hirunpetcharat C; Wipasa J; Sakkhachornphop S; Nitkumhan T; Zheng YZ; Pichyangkul S; Krieg AM; Walsh DS; Heppner DG; Good MF
    Vaccine; 2003 Jun; 21(21-22):2923-32. PubMed ID: 12798636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses induced by recombinant ALV-A gp85 protein vaccine combining with CpG-ODN adjuvant in breeder hens and the protection for their offspring against early infection.
    Zhang D; Li H; Zhang Z; Sun S; Cheng Z; Liu J; Zhao P; Ren Q; Guo H
    Antiviral Res; 2015 Apr; 116():20-6. PubMed ID: 25637708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.